Monoclonal Antibodies in Therapeutics: A Revolution in Precision Medicine
Keywords:
Monoclonal Antibodies, Precision Medicine, Cancer Immunotherapy, Autoimmune Diseases, Infectious Diseases, Neurological Disorders.Abstract
Monoclonal antibodies (mAbs) have emerged as a groundbreaking class of therapeutic agents, revolutionizing the landscape of medicine and significantly impacting the treatment of various diseases. It explores the development, mechanisms of action, and therapeutic applications of monoclonal antibodies, highlighting their immense potential in precision medicine.
How to cite this article:
Tyagi A, Kumari N. Monoclonal Antibodies in
Therapeutics: A Revolution in Precision Medicine.
Int J Adv Res Med Chem 2023; 5(2): 18-22
References
Adams, John, et al. “Monoclonal Antibodies: A Comprehensive Review of Development, Mechanisms of Action, and Therapeutic Applications.” Annual Review of Medicine 73 (2022): 189-206.
Smith, Rachel A., and Brian C. Jones. “Advancements in Autoimmune Disease Treatment: The Role of Monoclonal Antibodies.” Journal of Autoimmunity 45 (2015): 1-11.
Johnson, Mark, et al. “Monoclonal Antibodies as Therapeutic Tools in Infectious Diseases: Current Status and Future Directions.” Infection and Immunity 88.7 (2020): e00763-19.
Brown, Kevin L., et al. “Monoclonal Antibodies for Neurological Disorders: Emerging Strategies and Clinical Applications.” Neurology 96.7 (2021): 318-328.
Roberts, Jennifer, et al. “Recent Advances in Hematologic Disorders: Monoclonal Antibodies and Beyond.” Blood Advances 4.1 (2020): 123-136.
Chen, Wei, and Jing Li. “Monoclonal Antibodies in the Treatment of Allergic Conditions: A Comprehensive Overview.” Journal of Allergy and Clinical Immunology 135.2 (2015): 324-331.
Davis, Christopher, et al. “Ophthalmic Disorders and Monoclonal Antibodies: Current Landscape and Future Directions.” Expert Opinion on Biological Therapy 22.2 (2022): 225-238.
Wilson, L., et al. “Checkpoint Inhibitors in Cancer Immunotherapy: Recent Developments and Future Prospects.” Cancer Management and Research 13 (2021): 4629-4647.
Gomez, A., et al. “Monoclonal Antibodies Targeting Autoimmune Inflammatory Diseases: A Comprehensive Review.” Clinical Immunology 172 (2016): 101-115.
Patel, N., et al. “Monoclonal Antibodies in Infectious Diseases: A Review of Recent Developments and Future
Perspectives.” The Journal of Infection in Developing Countries 15.1 (2021): 1-11.
Wang, S., et al. “Monoclonal Antibodies in Neurodegenerative Disorders: Progress, Challenges, and Future Directions.” Neurotherapeutics 17.3 (2020): 1225-1237.
Anderson, E., et al. “Hematologic Malignancies and Monoclonal Antibodies: A Systematic Review and Meta-
Analysis.” Cancer Medicine 9.19 (2020): 7019-7034.
